Search company, investor...

Vascular Magnetics


Series A | Alive

Total Raised


Last Raised

$7M | 11 yrs ago

About Vascular Magnetics

Vascular Magnetics is developing therapeutic products based on the magnetic targeting of drug-loaded biodegradable particles. The company's first product in development is a treatment for peripheral artery disease that is designed to target anti-restenotic drugs specifically to diseased arterial sites and deliver doses not achievable with a drug eluting stent. The company's approach, called Vascular Magnetic Intervention (VMI), combines a magnetic targeting catheter, and external magnetic device, along with drug-loaded biodegradable particles. Peripheral artery disease is a growing chronic condition characterized by obstruction of the arteries in the legs. Intermittent claudication (crippling leg pain) is the most common and debilitating symptom of PAD. PAD can progress to compromise the blood supply to the affected leg, resulting in diminished function and quality of life, gangrene and subsequent amputation. All PAD patients have a higher risk of strokes and heart attacks. Risk factors for the condition include diabetes, elevated cholesterol, and hypertension. Current treatments, including angioplasty, grafts, stents and drug eluting stents are not particularly effective, with restenosis occurring at an annual rate of 20-40 percent. PAD-related costs, including amputation and amputation-related deaths, are estimated at up to $290 billion per year in the US alone.

Headquarters Location

3711 Market Street 8th Floor

Philadelphia, Pennsylvania, 19104,

United States

Missing: Vascular Magnetics's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Vascular Magnetics's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Vascular Magnetics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Vascular Magnetics is included in 1 Expert Collection, including Diabetes.



1,903 items

Latest Vascular Magnetics News

Vascular Magnetics, Inc.: Series A $7M

Jan 4, 2013

Vascular Magnetics (Philadelphia, PA) a development-stage medical device focused on magnetically targeted drug delivery for the treatment of peripheral artery disease, closed a $7M Series A financing. Note: Closing out 1Q deals. Thanx for your patience as we play catch-up. Welcome to Where Ever you Are 1   Venture Capital Investors

Vascular Magnetics Frequently Asked Questions (FAQ)

  • Where is Vascular Magnetics's headquarters?

    Vascular Magnetics's headquarters is located at 3711 Market Street, Philadelphia.

  • What is Vascular Magnetics's latest funding round?

    Vascular Magnetics's latest funding round is Series A.

  • How much did Vascular Magnetics raise?

    Vascular Magnetics raised a total of $7M.

  • Who are the investors of Vascular Magnetics?

    Investors of Vascular Magnetics include Devon Park Bioventures.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.